On Wednesday, pharmaceutical giant Merck made a historic announcement: it would widely share its Covid-19 therapy drug patents royalty-free to enable mass production for the…
July 28, 2022 UPDATE – Through our advocacy and research, JLens has identified ten companies that have scored highly based on our recommended best practices.…
Companies hate controversy. Controversy threatens a company’s reputation and future earnings. With the dramatic growth of corporate social responsibility over the past decade, activists have…
The Chicago-based multinational investment company Morningstar was placed on JLens’s “Do Not Invest” list in January over their alleged support for BDS.